For Zika virus testing information, visit the Lab Professionals page.
Zika virus is a nationally notifiable condition and is a Wisconsin disease surveillance category II disease. Health care providers should report suspected Zika virus infections to the patient’s local public health department.
Multiple travel-associated Zika virus infections in Wisconsin residents were identified during 2016 and 2017, but no infections have been detected since 2017. Since Zika virus infection during pregnancy is associated with microcephaly and other serious brain anomalies, it is important for providers to discuss Zika virus prevention with all patients of childbearing age, especially with pregnant women and with both men and women who are planning a pregnancy.
Wisconsin Specific Guidance
Clinical Guidance for Health Care Providers
The evaluation of Zika virus infections globally and in the U.S. are ongoing. Wisconsin DHS and the CDC continue to update their guidance for health professionals as new information is obtained.
- CDC MMWR - Zika Reports
- CDC Health Alert Network: CDC guidance for travel and testing of pregnant women for Zika virus infection related to the investigation for local mosquito-borne Zika virus transmission in Miami-Dade and Broward counties, Florida
- Recommendations for Zika virus testing pertaining to assays available at commercial laboratories (PDF)
- CDC Health Update - CDC recommendations for subsequent Zika IgM antibody testing (in the setting of commercially available molecular PCR detection tests) - June 21, 2016
- CDC - Zika virus information
For more information on testing procedures.
